Gene editing, also known as genome editing, has widespread applications in various domains including biomedical research, agriculture, and industrial biotechnology. Gene editing tools such as CRISPR-Cas9 allow genomic modifications to be made precisely and efficiently at desired locations in the genome, opening up avenues for diseases to be treated or prevented at the genetic level. These tools also enable modifications in plants and animals to create resilient crops or livestock better suited for the environment and human needs.

The global gene editing market is estimated to be valued at US$4 billion in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024-2030.

R&D investments from both private players and government organizations have increased over the years, aiding advancements in Gene Editing Market Demand technologies and facilitating drug and therapy development for various diseases.

Key Takeaways

Key players operating in the gene editing market are CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Sangamo Therapeutics, and Precision Biosciences. Growing demand for gene and cell therapies to treat genetic disorders is boosting market growth. Additionally, increasing investments by market players in agricultural biotechnology for developing resilient crops are expanding the global footprint of the gene editing industry.

Get More Inisights On- Gene Editing Market